N Engl J Med
COVID-19COVID-19 Nucleic Acid TestingCOVID-19 Vaccines
Beth Emmie Safirstein
NPI1851565287
- Part D claims, 2022
- 20
- Publications
- 11
- Clinical trials
- 15
- Industry payments
- $3,525
- State license
- 1
- Practice address
- 911 E Hallandale Beach Blvd, Hallandale Beach, FL 33009-4427
- Practice phone
- Call (954) 455-5757
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Beth Safirstein's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Beth Emmie Safirstein is a neurologist in Hallandale Beach, Florida
Beth Safirstein practices in Hallandale Beach, Florida.
Beth Safirstein's NPI, 1851565287, was assigned on April 16, 2008. Beth Safirstein graduated from Indiana University School Of Medicine in 1996. Beth Safirstein holds Florida license BS6587476.
NPI and contact details
- NPI
- 1851565287NPI Registry (opens in a new tab)
- NPI enumeration date
- April 16, 2008
- NPI status
- Active
- Practice phone
- (954) 455-5757
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Medical school graduation
- 1996
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Beth Emmie Safirstein's practice address is in Hallandale Beach, Florida
Beth Safirstein's practice address in the NPI Registry is 911 E Hallandale Beach Blvd, Hallandale Beach, FL 33009-4427. The practice phone is (954) 455-5757.
- NPI Registry address911 E Hallandale Beach Blvd, Hallandale Beach, FL 33009-4427Phone(954) 455-5757
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Beth Emmie Safirstein's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Beth Safirstein practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Beth Safirstein's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Beth Safirstein practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Beth Emmie Safirstein is one of 1,297 neurologists in Florida
Neurology is Beth Safirstein's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Beth Safirstein is board certified in neurology by the National Board of Physicians and Surgeons. Beth Safirstein is licensed in Florida.
Specialties and state licenses
- Neurology, FloridaPrimary
Neurologists near Beth Safirstein
Counts of neurologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Beth Emmie Safirstein's patients have a median age of 56
Across all payers, Dmand AI patient panel data puts Beth Safirstein's median patient age at 56, with 50% women.
Beth Safirstein's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 56
Patient panel by sex, all payers
- Women50%
- Men50%
Source: Dmand AI Patient Panel Data
Beth Emmie Safirstein wrote 20 Medicare Part D claims in 2022
In 2022, Beth Safirstein wrote 20 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $324 in total drug cost. In 2021, CMS named 53 claims across 1 drug.
Part D claims, 202220
Drugs named by CMS1
Total drug cost$324
Beth Safirstein's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2021 to 2022
- 2021
- 2022
- Claims for drugs CMS names
- 2021: 532022: 2062%
Drugs named by CMS: 1 in 2022, 1 in 2021.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find neurologists like Beth Safirstein by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Beth Emmie Safirstein has 11 publications on record
Dmand AI links 11 papers to Beth Safirstein, published from 2006 to 2021. The most frequent topics are Cross-Over Studies, Double-Blind Method and Parkinson Disease. Beth Safirstein's most frequent co-authors are Aaron L. Ellenbogen, DO, Marc Edward Agronin, MD and Julie A. Ake, MD.
Papers11
Years published2006 to 2021
Beth Safirstein's papers by year, 2006 to 2021
Topics Beth Safirstein writes about most
- Cross-Over Studies
- Double-Blind Method
- Parkinson Disease
- Administration, Inhalation
- Alzheimer Disease
- Amyloid beta-Peptides
- Antiparkinson Agents
- Carbidopa
Beth Safirstein's most frequent co-authors
- Aaron L. Ellenbogen, DO3 shared papers
- Marc Edward Agronin, MD1 shared paper
- Julie A. Ake, MD1 shared paper
Recent publications by Beth Safirstein
Administration, InhalationAdministration, OralAntiparkinson Agents
Parkinsonism Relat Disord
Administration, InhalationAntiparkinson AgentsCarbidopa
Diabetic NeuropathiesDouble-Blind MethodLamotrigine
See who Beth Safirstein researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Beth Safirstein works with, so you can find a warm path to the right neurologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Beth Emmie Safirstein has worked on 15 clinical trials
Dmand AI links Beth Safirstein to 15 clinical trials, 7 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Parkinson Disease, Parkinsonian Disorders and Alzheimer Disease. Open Payments lists research payments to Beth Safirstein that name 2 trials.
Clinical trials with Beth Safirstein by phase
- 7Phase 1: 7 trials
- 1Phase 2: 1 trial
- 2Phase 2/3: 2 trials
- 3Phase 3: 3 trials
- NonePhase 4: no trials
Conditions in Beth Safirstein's trials
- Parkinson Disease
- Parkinsonian Disorders
- Alzheimer Disease
- Cognitive Dysfunction
- Tauopathies
Investigators on the most trials with Beth Safirstein
- Gustavo Alva, MD4 shared trials
- Robert Gabriel Feldman, MD4 shared trials
- Stephen S. Flitman, MD4 shared trials
Recent clinical trials with Beth Safirstein
COVID-19Pneumonia, ViralCV2CoV (12 µg)CV2CoV (16 µg)CV2CoV (20 µg)
Alzheimer DiseaseTauopathiesSimufilam
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine (opens in a new tab)
CompletedPhase 3
Migraine without AuraMigraine with AuraDihydroergotamine
A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD (opens in a new tab)
CompletedPhase 1
Cognitive DysfunctionCognition DisordersACU193
A Study to Assess Single and Multiple Doses of IkT-148009 in Healthy Elderly Participants and Parkinson's Patients (opens in a new tab)
CompletedPhase 1
Parkinson DiseaseParkinsonian DisordersIkT-148009
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Beth Emmie Safirstein received $3,525 in industry payments from 2016 to 2025
CMS Open Payments shows 23 general payments to Beth Safirstein from 5 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 45% of the total. Merck Sharp & Dohme Corporation paid the most, $1,662. It also lists 46 research payments totaling $635,302 from 2016 to 2023, naming 2 clinical trials.
General payments to Beth Safirstein by program year, 2016 to 2025
General payments to Beth Safirstein by kind, 2016 to 2025
$3.5Kin total
- Travel and lodging$1,58545%
- Consulting fees$1,00028%
- Food and beverage$92426%
- Education$160%
Companies that paid Beth Safirstein the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Beth Emmie Safirstein has 4 awards and honors on record
Dmand AI lists 4 awards for Beth Safirstein, most recently Conference Educational Grant in 2000.
Awards and honors for Beth Safirstein
- 2000
- Conference Educational Grant
- Strathmore's WHO's WHO
- 1998
- George Paff Teaching Award
- 1988
- Educational Grant
Source: Dmand AI Professional Profile Data
Beth Emmie Safirstein graduated from Indiana University School Of Medicine
Beth Safirstein graduated from Indiana University School Of Medicine in 1996.
- Medical school
- Board certified in neurology
Source: Dmand AI Professional Profile Data
Sources for Beth Emmie Safirstein's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Beth Emmie Safirstein
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Beth Emmie Safirstein's NPI number?
Beth Emmie Safirstein's NPI number is 1851565287. It was assigned on April 16, 2008, and it is active in the NPI Registry.
What does Beth Emmie Safirstein specialize in?
Beth Emmie Safirstein is a neurologist in Hallandale Beach, Florida. The primary specialty in the NPI Registry is Neurology Physician (taxonomy code 2084N0400X).
Where does Beth Emmie Safirstein practice?
Beth Safirstein practices at 911 E Hallandale Beach Blvd, Hallandale Beach, FL 33009-4427.
What is Beth Emmie Safirstein's office phone number?
The practice phone on file for Beth Safirstein is (954) 455-5757.
What is Beth Emmie Safirstein's medical license number?
Beth Safirstein holds Florida license BS6587476.
Is Beth Emmie Safirstein board certified?
Yes. Beth Safirstein is board certified in neurology by the National Board of Physicians and Surgeons.
Where did Beth Emmie Safirstein go to medical school?
Beth Safirstein graduated from Indiana University School Of Medicine in 1996.
What drugs does Beth Emmie Safirstein prescribe most?
In 2022 Medicare Part D data, Beth Safirstein's most prescribed drugs by claims were Donepezil HCl.
Has Beth Emmie Safirstein received payments from drug or device companies?
CMS Open Payments shows $3,525 in general payments to Beth Safirstein from 5 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.
How long has Beth Emmie Safirstein been practicing?
Beth Safirstein graduated from medical school in 1996, 30 years ago.
Does Beth Emmie Safirstein do research?
Dmand AI links 11 publications to Beth Safirstein, published from 2006 to 2021. Beth Safirstein has worked on 15 clinical trials.
Who does Beth Emmie Safirstein publish with?
Beth Safirstein's most frequent co-authors are Aaron L. Ellenbogen, DO (3 shared papers), Marc Edward Agronin, MD (1 shared paper) and Julie A. Ake, MD (1 shared paper).
Selling to neurology practices?
See neurologists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card